Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots

Moderna's total revenue for the third quarter still topped Wall Street's expectations despite plummeting demand for its Covid-19 shot.

from Health and Science https://ift.tt/4FVkR08
https://ift.tt/l748Mxg
https://ift.tt/e3KISlr